RDIF partners Mumtalakat, Binnopharm Group to produce Sputnik V coronavirus vaccine in Bahrain
Jun 03, 2021
Saint-Petersburg [Russia], June 3 : The Russian Direct Investment Fund (RDIF), Bahrain's Mumtalakat Holding Company (Mumtalakat, sovereign wealth fund of the Kingdom of Bahrain) and Binnopharm Group (a subsidiary of Sistema PJSFC) on Thursday signed an MoU to establish a new vaccine production facility in Bahrain to manufacture and distribute the Russian Sputnik V coronavirus vaccine across the Middle East and North Africa (MENA) region.